UK NICE issues first guidance under new medtech evaluation programme
This article was originally published in RAJ Devices
The UK health technology assessment body, NICE, has published the first draft guidance under its medical devices evaluation programme, which aims to accelerate the adoption of new technologies in the National Health Service1,2.
You may also be interested in...
Mexico's Genomma Lab recorded strong double-digit growth for its OTC business in the second quarter as sales more than doubled at its US consumer health operation.
New board directors named at Autolus Therapeutics, Beximco Pharmaceuticals, Tetraphase Pharmaceuticals and Vesigen.
After launching a biosimilar to Avastin (bevacizumab) in India, Cadila Pharma has now also launched rituximab and teriparatide biosimilars in its domestic market.